News & Updates

Adjunctive brivaracetam (BRV) reduces seizure frequency and improves response in Asian adults with uncontrolled focal-onset seizures (FOS), findings from the phase III therapeutic confirmatory EP0083 study suggest.

In the treatment of psoriasis, selective inhibition of tyrosine kinase 2 (TYK2) with zasocitinib appears to have superior effects compared with placebo, with greater skin clearance observed over 12 weeks, according to data from a phase 2b study.

Individuals who have been vaccinated against COVID-19 appear to have a risk of new-onset seizure that is similar to that observed among unvaccinated individuals, according to the results of a meta-analysis.

In women with elevated antimüllerian hormone (AMH) levels, tailoring follitropin delta doses based on AMH level and weight for ovarian stimulation helps improve live birth rates, according to the results of a meta-analysis.

Use of sphingosine 1-phosphate receptor modulators (S1PRM) demonstrates safety and efficacy in the treatment of moderate-to-severe ulcerative colitis (UC), results of a recent study have shown.

The ENVIE* study demonstrates the real-world effectiveness of nirsevimab against hospitalization for bronchiolitis associated with respiratory syncytial virus (RSV) among infants <12 months of age in France.

Several classes of commonly prescribed oral antibiotics appear to carry an increased risk of serious cutaneous adverse drug reactions (cADRs), according to a study.

Children with invasive fungal sinusitis may benefit from early diagnosis, aggressive surgical intervention, and combined antifungal therapy to achieve better outcomes, suggests a study.